SHC · XBRL financial data
Sotera Health Company financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (SHC's year ends in late December)
| In millions of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue from contracts with customers | 931 | 1,004 | 1,049 | 1,100 | 1,164 |
| Cost of revenue | 413 | 447 | 472 | 498 | 518 |
| Gross profit | 519 | 557 | 577 | 602 | 646 |
| Selling, general and administrative | 198 | 246 | 237 | 243 | 253 |
| Total operating expenses | 262 | 309 | 300 | 305 | — |
| Operating income (loss) | 257 | 248 | 277 | 298 | — |
| Other income (expense) | 15 | 6 | 7 | 5 | 9 |
| Income tax expense (benefit) | 59 | (10) | 55 | 69 | 70 |
| Net income (loss) | 117 | (234) | 51 | 44 | 78 |
| Earnings per share, basic USD per share | 0.41 | (0.83) | 0.18 | 0.16 | 0.27 |
| Earnings per share, diluted USD per share | 0.41 | (0.83) | 0.18 | 0.16 | 0.27 |
| Weighted average shares, basic millions of shares | 279 | 280 | 281 | 283 | 284 |
| Weighted average shares, diluted millions of shares | 279 | 280 | 283 | 285 | 286 |
Balance sheet
CSVFiscal years (SHC's year ends in late December)
| In millions of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 107 | 395 | 296 | 277 | 345 |
| Accounts receivable | 108 | 118 | 148 | 140 | 139 |
| Inventory | 54 | 37 | 48 | 49 | 54 |
| Prepaid and other current assets | 72 | 81 | 54 | 51 | 65 |
| Total current assets | 346 | 645 | 557 | 526 | 613 |
| Property and equipment, net | 651 | 775 | — | — | — |
| Right-of-use asset | 40 | 26 | 24 | 28 | 33 |
| Goodwill | 1,120 | 1,102 | 1,111 | 1,081 | 1,103 |
| Total assets | 2,790 | 3,118 | 3,130 | 3,072 | 3,263 |
| Accounts payable | 73 | 74 | 71 | 55 | 78 |
| Accrued liabilities | 62 | 490 | 122 | 90 | 125 |
| Current portion of long-term debt | 0 | 197 | 5 | 15 | 14 |
| Total current liabilities | 161 | 792 | 231 | 191 | 250 |
| Long-term debt | 1,744 | 1,747 | 2,224 | 2,208 | 2,127 |
| Lease liability, non-current | 33 | 22 | 20 | 24 | 30 |
| Total liabilities | 2,203 | 2,767 | 2,687 | 2,667 | 2,657 |
| Accumulated deficit | (472) | (706) | (654) | (610) | (532) |
| Total stockholders' equity | 586 | 350 | 444 | 405 | 606 |
| Total liabilities and equity | 2,790 | 3,118 | 3,130 | 3,072 | 3,263 |
| Common shares outstanding (cover page) millions of shares | 283 | 282 | 283 | 283 | 284 |
Cash flows
CSVFiscal years (SHC's year ends in late December)
| In millions of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Net income (loss) | 117 | (234) | 51 | 44 | 78 |
| Stock-based compensation | 14 | 21 | 32 | 37 | 31 |
| Depreciation and amortization | 64 | 64 | 77 | 84 | 95 |
| Net cash from operating activities | 282 | 278 | (148) | 224 | 287 |
| Purchases of property and equipment | 102 | 182 | 215 | 179 | 138 |
| Net cash from investing activities | (160) | (182) | (215) | (179) | (135) |
| Proceeds from issuing common stock | 0 | 0 | — | — | — |
| Share repurchases | 0 | 0 | — | — | — |
| Dividends paid | 0 | — | — | — | — |
| Proceeds from long-term debt | 0 | 200 | 500 | 2,259 | 0 |
| Repayments of long-term debt | 100 | 0 | 3 | 2,264 | 86 |
| Net cash from financing activities | (117) | 198 | 266 | (51) | (101) |
| Net change in cash | 4 | 289 | (95) | (23) | 68 |
Compare with peers
SIC 8090 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Sotera Health | 412 | 325 | 111* | 285.6M | 10-QSep 30, 2026 |
| Progyny | 153 | 351 | 50* | 76.7M | 10-QJun 30, 2026 |
| Acadia Healthcare Company | 163 | 895 | 98* | 93.0M | 10-QSep 30, 2026 |
| Concentra Group Holdings Parent | 158 | 606 | 135* | 127.5M | 10-QJun 30, 2026 |
| agilon health | 174 | 1,519 | 50* | 16.8M | 10-QSep 30, 2026 |
| Park Dental Partners | 24 | 66 | 4.7* | 4.8M | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.